tangeretin has been researched along with Colonic Neoplasms in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bielawska-Pohl, A; Duarte, N; Duś, D; Ferreira, MJ; Michalak, K; Paprocka, M; Sroda-Pomianek, K; Wesołowska, O; Wiśniewski, J | 1 |
| Bao, H; Li, Z; Zheng, N; Zhi, Y | 1 |
| Chen, WJ; Ho, CT; Lin, JK; Lin-Shiau, SY; Pan, MH | 1 |
| Ferguson, PJ; Koropatnick, J; Morley, KL | 1 |
| Canada, AT; Nguyen, TD | 1 |
5 other study(ies) available for tangeretin and Colonic Neoplasms
| Article | Year |
|---|---|
Multidrug resistance reversal and apoptosis induction in human colon cancer cells by some flavonoids present in citrus plants.
Topics: Algorithms; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Caspase 3; Citrus; Colonic Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flavanones; Flavones; Flavonoids; Humans; Molecular Structure; Rhodamine 123 | 2012 |
Synergistic Effect of Tangeretin and Atorvastatin for Colon Cancer Combination Therapy: Targeted Delivery of These Dual Drugs Using RGD Peptide Decorated Nanocarriers.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Atorvastatin; Cell Line; Cell Proliferation; Cell Survival; Colonic Neoplasms; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; Female; Flavones; Humans; Kinetics; Ligands; Mice; Mice, Inbred BALB C; Molecular Structure; Nanoparticles; Neoplasms, Experimental; Oligopeptides; Particle Size | 2020 |
Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells.
Topics: Adenocarcinoma; Antineoplastic Agents; CDC2-CDC28 Kinases; Cell Cycle; Cell Cycle Proteins; Cell Division; Colonic Neoplasms; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p27; Cyclin-Dependent Kinases; DNA-Binding Proteins; Flavones; Flavonoids; G1 Phase; Humans; Kinetics; Phosphorylation; Phytotherapy; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Retinoblastoma Protein; Structure-Activity Relationship; Time Factors; Transcription Factors; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2002 |
Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Dose-Response Relationship, Drug; Female; Flavones; G1 Phase; HT29 Cells; Humans; Molecular Structure; Time Factors | 2007 |
Citrus flavonoids stimulate secretion by human colonic T84 cells.
Topics: Adenocarcinoma; Carbachol; Chlorides; Citrus; Colon; Colonic Neoplasms; Cyclic AMP; Cyclic GMP; Drug Synergism; Flavanones; Flavones; Flavonoids; Glycosylation; Humans; Kinetics; Tumor Cells, Cultured | 1993 |